# Loss of Pum2 exacerbates colitis by disrupting macrophage–epithelial crosstalk and promoting epithelial necroptosis

**Authors:** Xuefei Wang, Xiaoxiao Han, Wenlin Qiu, Lijuan Jiang, Xiaoru Duan, Xiaojing Liu

PMC · DOI: 10.1038/s41420-026-03041-x · Cell Death Discovery · 2026-03-20

## TL;DR

This study shows that reduced levels of the protein Pum2 worsen colitis by increasing inflammation and causing cell death in the gut lining.

## Contribution

The study identifies Pum2 as a novel regulator of intestinal inflammation and reveals its role in macrophage–epithelial interactions during colitis.

## Key findings

- Pum2 deficiency in colitis models leads to increased macrophage inflammation and epithelial necroptosis.
- Reduced Pum2 in UC patients correlates with higher disease activity and impaired intestinal barrier function.
- Pum2 loss promotes a self-perpetuating cycle of inflammation and epithelial cell death via TNFα and ROS signaling.

## Abstract

Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder characterized by persistent mucosal immune activation and compromised epithelial barrier function. In this study, we identify the RNA-binding protein PUMILIO2 (Pum2) as a previously unrecognized regulator of intestinal inflammation. Analysis of colonic tissues from UC patients revealed reduced Pum2 expression, which inversely correlated with disease activity. In dextran sulfate sodium (DSS)-induced colitis models, Pum2 deficiency exacerbated mucosal injury, accompanied by heightened macrophage inflammation. Mechanistically, Pum2 loss during colitis drives macrophage hyperactivation and TNFα-dependent epithelial necroptosis, which together intensify pathogenic macrophage–epithelial interactions and barrier breakdown. The dynamic downregulation of Pum2 in active inflammation underscores its potential as a therapeutic target for modulating macrophage–epithelial interactions and restoring intestinal barrier integrity in the context of colitis.

Abstract Figure. Pum2 deficiency aggravates colitis via macrophage–epithelial crosstalk driving inflammation and necroptosis. Left: Pum2 loss promotes macrophage-driven inflammation, with increased chemokine expression, macrophage infiltration, and a pro-inflammatory phenotype characterized by TNFα secretion. Right: Macrophage–epithelial crosstalk triggers epithelial necroptosis. Proinflammatory signals from Pum2-deficient macrophages sensitize epithelial cells to TNFα-induced death. Simultaneously, epithelial Pum2 loss elevates ROS, facilitating RIPK1, RIPK3, and MLKL phosphorylation. This synergistic cascade amplifies necroptosis and establishes a self-perpetuating loop of barrier disruption and inflammation.

Abstract Figure. Pum2 deficiency aggravates colitis via macrophage–epithelial crosstalk driving inflammation and necroptosis. Left: Pum2 loss promotes macrophage-driven inflammation, with increased chemokine expression, macrophage infiltration, and a pro-inflammatory phenotype characterized by TNFα secretion. Right: Macrophage–epithelial crosstalk triggers epithelial necroptosis. Proinflammatory signals from Pum2-deficient macrophages sensitize epithelial cells to TNFα-induced death. Simultaneously, epithelial Pum2 loss elevates ROS, facilitating RIPK1, RIPK3, and MLKL phosphorylation. This synergistic cascade amplifies necroptosis and establishes a self-perpetuating loop of barrier disruption and inflammation.

## Linked entities

- **Genes:** PUM2 (pumilio RNA binding family member 2) [NCBI Gene 23369], RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035], MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259]
- **Proteins:** pum2 (pumilio RNA-binding family member 2), TNF (tumor necrosis factor)
- **Diseases:** ulcerative colitis (MONDO:0005101), colitis (MONDO:0005292)

## Full-text entities

- **Genes:** OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, PUM2 (pumilio RNA binding family member 2) [NCBI Gene 23369] {aka PUMH2, PUML2}, Pum2 (pumilio RNA-binding family member 2) [NCBI Gene 80913] {aka 5730503J23Rik, Pumm2}, Ccl12 (C-C motif chemokine ligand 12) [NCBI Gene 20293] {aka MCP-5, Scya12}, Ccl8 (C-C motif chemokine ligand 8) [NCBI Gene 20307] {aka 1810063B20Rik, HC14, MCP-2, Mcp2, Scya8}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, CYBB (cytochrome b-245 beta chain) [NCBI Gene 1536] {aka AMCBX2, CGD, CGDX, GP91-1, GP91-PHOX, GP91PHOX}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, Atg16l1 (autophagy related 16 like 1) [NCBI Gene 77040] {aka 1500009K01Rik, Apg16l, Atg16l, WDR30}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, Cldn1 (claudin 1) [NCBI Gene 12737], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Fadd (Fas associated via death domain) [NCBI Gene 14082] {aka Mort1/FADD}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, Mlkl (mixed lineage kinase domain-like) [NCBI Gene 74568] {aka 9130019I15Rik}, Rbp4 (retinol binding protein 4, plasma) [NCBI Gene 19662] {aka Rbp-4}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) [NCBI Gene 19766] {aka D330015H01Rik, RIP, RIP-1, Rinp, Rip1}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Cxcl9 (C-X-C motif chemokine ligand 9) [NCBI Gene 17329] {aka CMK, Mig, MuMIG, Scyb9, crg-10}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, Xbp1 (X-box binding protein 1) [NCBI Gene 22433] {aka D11Ertd39e, TREB-5, TREB5, XBP-1}, Elavl1 (ELAV like RNA binding protein 1) [NCBI Gene 15568] {aka 2410055N02Rik, HUR, Hua}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}
- **Diseases:** splenomegaly (MESH:D013163), intestinal injury (MESH:D007410), carcinogenesis (MESH:D063646), IBD (MESH:D015212), CRC (MESH:D015179), TTP (MESH:D011697), mitochondrial dysfunction (MESH:D028361), gastrointestinal inflammatory (MESH:D005767), cytotoxicity (MESH:D064420), DSS (MESH:C562576), chronic (MESH:D002908), CD (MESH:D003424), weight loss (MESH:D015431), cancer (MESH:D009369), rectal bleeding (MESH:D012002), UC (MESH:D003093), body mass (MESH:C536030), epithelial injury (MESH:D009375), colonic (MESH:D003108), acute intestinal inflammation (MESH:D007249), colitis-associated cancer (MESH:D000083023), mucosal injury (MESH:D052016), colitis (MESH:D003092), necrosis (MESH:D009336)
- **Chemicals:** T (MESH:D014316), streptomycin (MESH:D013307), DMEM (-), MitoSOX (MESH:C521281), MitoSOX  Red (MESH:C000597839), AOM (MESH:D001397), DAPI (MESH:C007293), eosin (MESH:D004801), penicillin (MESH:D010406), H2O2 (MESH:D006861), H&amp;E (MESH:D006371), PI (MESH:D010716), PBS (MESH:D007854), ROS (MESH:D017382), DCF (MESH:D015649), water (MESH:D014867), alpha-MEM (MESH:C420642), hematoxylin (MESH:D006416), brefeldin A (MESH:D020126), DSS (MESH:D016264), NO (MESH:D009614), LPS (MESH:D008070)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T300A
- **Cell lines:** HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), Caco2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039920/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039920/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039920/full.md

---
Source: https://tomesphere.com/paper/PMC13039920